AshokSrinivasanMD

Pediatric Hematology & Oncology • Memphis, TN

Assistant Professor, Pediatrics, University of Tennessee Health Science Center College of Medicine

Join to view full profile

Dr. Srinivasan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Srinivasan's full profile

Already have an account?

Office
262 Danny Thomas Pl
Memphis, TN 38105
Phone+1 901-595-3006

Fax+1 901-595-3842

Education & Training

University of TennesseeFellowship, Pediatric Infectious Diseases, 2006 - 2008
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Pediatric Hematology/Oncology, 1993 - 1996
Maulana Azad Medical CollegeClass of 1985

Certifications & Licensure

CA State Medical License 1993 - Present
TN State Medical License 2008 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
American Board of Pediatrics Pediatric Infectious Diseases

Clinical Trials

Dose Escalation Study Of Palifermin in Pediatric Research Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation Start of enrollment: 2007 Sep 01
Completed
Phase 1
A Pediatric Study of a Plerixafor Containing Regimen In Second Allogeneic Stem Cell Transplantation Start of enrollment: 2010 May 01
Completed
Phase 1

Publications & Presentations

PubMed

19 citations
Increasing prevalence of nasal and rectal colonization with methicillin-resistant Staphylococcus aureus in children with cancer.
Ashok Srinivasan, Steven E. Seifried, Liang Zhu, Deo Kumar Srivastava, Rosalie Perkins
Pediatric Blood & Cancer. 2010-12-15
32 citations
Improved survival rate in T-cell depleted haploidentical hematopoietic cell transplantation over the last 15 years at a single institution.
Ewelina Mamcarz, Renee Madden, Amr Qudeimat, Ashok Srinivasan, Aimee C Talleur
Bone Marrow Transplantation. 2020-05-01
44 citations
Selective T-cell depletion targeting CD45RA reduces viremia and enhances early T-cell recovery compared with CD3-targeted T-cell depletion.
Brandon M. Triplett, Brad Muller, Guolian Kang, Ying Li, Shane J Cross
Transplant Infectious Disease. 2018-02-01

Journal Articles

Selective T‐Cell Depletion Targeting CD45RA Reduces Viremia and Enhances Early T‐Cell Recovery Compared with CD3‐Targeted T‐Cell Depletion
Brandon M Triplett, David R Shook, Ewelina Mamcarz, Randall T Hayden, Shane J Cross, Ashok Srinivasan, Transplant Infectious Disease